Chloe Gui1, Suzanne E Kosteniuk1, Jonathan C Lau2,3,4, Joseph F Megyesi1,5. 1. Department of Clinical Neurological Sciences (Neurosurgery), Western University, London, ON, Canada. 2. Department of Clinical Neurological Sciences (Neurosurgery), Western University, London, ON, Canada. jonathan.lau@londonhospitals.ca. 3. Imaging Research Laboratories, Robarts Research Institute, London, ON, Canada. jonathan.lau@londonhospitals.ca. 4. London Health Sciences Centre, University Hospital, 339 Windermere Road, London, ON, N6A 5A5, Canada. jonathan.lau@londonhospitals.ca. 5. Department of Pathology (Neuropathology), Western University, London, ON, Canada.
Abstract
BACKGROUND: Diffuse low-grade gliomas (LGGs) are infiltrative, slow-growing primary brain tumors that remain relatively asymptomatic for long periods of time before progressing into aggressive and fatal high-grade gliomas. METHODS: We retrospectively identified LGG patients with numerous (≥ 8) serial magnetic resonance imaging (MRI) studies. Tumor volumes were measured by manual segmentation on serial imaging to study the natural history and growth of the lesion. Patient demographic information, tumor characteristics, and histological data were collected from electronic medical records and paper charts. RESULTS: Out of 74 LGG patients, 10 patients (13.5%) were identified to meet the study criteria with number of MRIs acquired ranging from 8 to 18 (median, 11.5) over a median of 79.7 months (range 39.8-113.8 months). Tumor diameter increased at a median of 2.17 mm/year in a linear trajectory. Cox regression analysis revealed that initial tumor volume was an independent predictor of time to clinical intervention, and Mann-Whitney U test found that patients younger than 50 years old had significantly slower-growing tumors. Clinical intervention was more likely for tumors above a volume threshold of 73.6 mL. CONCLUSION: We retrospectively analyzed the natural history of LGGs of patients managed at a single institution with numerous serial MRI scans. Comparisons of our cohort to the literature suggest that this is a subset of particularly slow-growing and low-risk tumors.
BACKGROUND: Diffuse low-grade gliomas (LGGs) are infiltrative, slow-growing primary brain tumors that remain relatively asymptomatic for long periods of time before progressing into aggressive and fatal high-grade gliomas. METHODS: We retrospectively identified LGG patients with numerous (≥ 8) serial magnetic resonance imaging (MRI) studies. Tumor volumes were measured by manual segmentation on serial imaging to study the natural history and growth of the lesion. Patient demographic information, tumor characteristics, and histological data were collected from electronic medical records and paper charts. RESULTS: Out of 74 LGG patients, 10 patients (13.5%) were identified to meet the study criteria with number of MRIs acquired ranging from 8 to 18 (median, 11.5) over a median of 79.7 months (range 39.8-113.8 months). Tumor diameter increased at a median of 2.17 mm/year in a linear trajectory. Cox regression analysis revealed that initial tumor volume was an independent predictor of time to clinical intervention, and Mann-Whitney U test found that patients younger than 50 years old had significantly slower-growing tumors. Clinical intervention was more likely for tumors above a volume threshold of 73.6 mL. CONCLUSION: We retrospectively analyzed the natural history of LGGs of patients managed at a single institution with numerous serial MRI scans. Comparisons of our cohort to the literature suggest that this is a subset of particularly slow-growing and low-risk tumors.
Authors: M C Zlatescu; A TehraniYazdi; H Sasaki; J F Megyesi; R A Betensky; D N Louis; J G Cairncross Journal: Cancer Res Date: 2001-09-15 Impact factor: 12.701
Authors: David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison Journal: Acta Neuropathol Date: 2016-05-09 Impact factor: 17.088
Authors: Jeremy Rees; Hilary Watt; H Rolf Jäger; Chris Benton; Daniel Tozer; Paul Tofts; Adam Waldman Journal: Eur J Radiol Date: 2008-07-15 Impact factor: 3.528
Authors: Michael Opoku-Darko; Stefan T Lang; James Artindale; J Gregory Cairncross; Robert J Sevick; John J P Kelly Journal: J Neurosurg Date: 2017-10-06 Impact factor: 5.115
Authors: C Houillier; X Wang; G Kaloshi; K Mokhtari; R Guillevin; J Laffaire; S Paris; B Boisselier; A Idbaih; F Laigle-Donadey; K Hoang-Xuan; M Sanson; J-Y Delattre Journal: Neurology Date: 2010-10-26 Impact factor: 11.800
Authors: Bibi L J Bouwen; Kay J Pieterman; Marion Smits; Clemens M F Dirven; Zhenyu Gao; Arnaud J P E Vincent Journal: Front Neurol Date: 2018-11-27 Impact factor: 4.003
Authors: M Visser; D M J Müller; R J M van Duijn; M Smits; N Verburg; E J Hendriks; R J A Nabuurs; J C J Bot; R S Eijgelaar; M Witte; M B van Herk; F Barkhof; P C de Witt Hamer; J C de Munck Journal: Neuroimage Clin Date: 2019-02-22 Impact factor: 4.881
Authors: Roberto Altieri; Francesco Certo; Giuseppe La Rocca; Antonio Melcarne; Diego Garbossa; Alberto Bianchi; Salvatore Crimi; Alessandro Pluchino; Simone Peschillo; Giuseppe M V Barbagallo Journal: Radiol Oncol Date: 2020-12-03 Impact factor: 2.991